Full Text
CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

Abstract

Authors

K. Raimundo C. Asche

Back to Volume 14, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×